These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2726755)

  • 1. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.
    Terwilliger EF; Godin B; Sodroski JG; Haseltine WA
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3857-61. PubMed ID: 2726755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative bioassay for HIV-1 based on trans-activation.
    Felber BK; Pavlakis GN
    Science; 1988 Jan; 239(4836):184-7. PubMed ID: 3422113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV.
    Dewhurst S; Sakai K; Bresser J; Stevenson M; Evinger-Hodges MJ; Volsky DJ
    J Virol; 1987 Dec; 61(12):3774-82. PubMed ID: 2446007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X gene can transactivate heterologous viral sequences.
    Twu JS; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2046-50. PubMed ID: 2538828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation.
    Sun XH; Baltimore D
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2143-6. PubMed ID: 2538833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.
    Kashanchi F; Wood C
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-shock induction of the human immunodeficiency virus long terminal repeat.
    Geelen JL; Minnaar RP; Boom R; van der Noordaa J; Goudsmit J
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2913-7. PubMed ID: 3183632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human immunodeficiency virus type 1 by DNA damage in human cells.
    Valerie K; Delers A; Bruck C; Thiriart C; Rosenberg H; Debouck C; Rosenberg M
    Nature; 1988 May; 333(6168):78-81. PubMed ID: 3129661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
    Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.
    Mosca JD; Bednarik DP; Raj NB; Rosen CA; Sodroski JG; Haseltine WA; Hayward GS; Pitha PM
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7408-12. PubMed ID: 2823260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV replication by capsid mutant C6b.
    Shimano R; Iida S; Fukumori T; Yamamoto Y; Kawamura M; Furuta RA; Adachi A
    Biochem Biophys Res Commun; 1998 Jan; 242(2):313-6. PubMed ID: 9446791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transactivation mediated by the TAT gene of human immunodeficiency virus in transgenic mice.
    Khillan JS; Deen KC; Yu SH; Sweet RW; Rosenberg M; Westphal H
    Nucleic Acids Res; 1988 Feb; 16(4):1423-30. PubMed ID: 3258064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3.
    Feng CP; Kulka M; Smith C; Aurelian L
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):25-35. PubMed ID: 8783793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.
    Horvat RT; Wood C; Balachandran N
    J Virol; 1989 Feb; 63(2):970-3. PubMed ID: 2911127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B-binding proteins induced by HSV-1 infection of U937 cells are not involved in activation of human immunodeficiency virus.
    Feng CP; Kulka M; Aurelian L
    Virology; 1993 Feb; 192(2):491-500. PubMed ID: 8380662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication.
    Ho WZ; Ayyavoo V; Srinivasan A; Stinski MF; Plotkin SA; Gönczöl E
    AIDS Res Hum Retroviruses; 1991 Aug; 7(8):689-95. PubMed ID: 1657075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity.
    Nahreini P; Mathews MB
    Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
    Kessler M; Mathews MB
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.